LAMIVUDINE
NDC 60429-354 · Golden State Medical Supply, Inc.
Generic namelamivudine
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LAMIVUDINE
Strength300 mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
Marketing categoryANDA
Packages
60429-354-30 — 30 TABLET, FILM COATED in 1 BOTTLE (60429-354-30)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
49702-203 — lamivudine, 49702-204 — lamivudine, 49702-205 — lamivudine, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 49702-246 — dolutegravir sodium and lamivudine, 50742-623 — Lamivudine, 50742-624 — Lamivudine, 51407-866 — Lamivudine, 57237-274 — Lamivudine, 60429-353 — lamivudine, 60505-3250 — Lamivudine, 60505-3251 — lamivudine, 60505-3252 — lamivudine, 60687-720 — Lamivudine, 62135-706 — lamivudine oral, 64380-710 — Lamivudine, 64380-711 — Lamivudine, 65862-025 — Lamivudine, 65862-026 — Lamivudine, 65862-036 — Lamivudine and Zidovudine, +32 more